Literature DB >> 3383870

Quantitative analysis of the signal-averaged QRS in patients with arrhythmogenic right ventricular dysplasia.

C Blomström-Lundqvist1, I Hirsch, S B Olsson, N Edvardsson.   

Abstract

Temporal signal averaging of the surface QRS (V1 + V3 + V5) was performed in 16 patients with arrhythmogenic right ventricular dysplasia and in 16 normal subjects. The differences between ARVD patients and normals were large for the filtered QRS duration (FQRSd) (146.2 +/- 18.9 ms vs. 91.8 +/- 4.1 ms, P less than 0.000001), the late potential duration (LPd) (83.5 +/- 23.3 ms vs. 23.6 +/- 4.6 ms, P less than 0.00001), the LPd/FQRSd ratio (53.9 +/- 10.1% vs. 25.8 +/- 5.1%, P less than 0.00001), the filtered QRS amplitude (234.0 +/- 61.1 microV vs. 429 +/- 94.2 microV, P less than 0.001), and the root mean square voltage of the signals in the terminal 40 and 50 ms of the FQRS (RMS40 and RMS50) (18.4 +/- 10.0 microV vs. 118.4 +/- 49.8 microV, P less than 0.0005 and 27.9 +/- 19.2 microV vs. 217.0 +/- 66.3 microV, P less than 0.000002). RMS50 less than 40 microV discriminated best between ARVD and normals (81% sensitivity and 100% specificity). The right-sided predominance of the abnormalities in ARVD was demonstrated by the significantly longer FQRSd and LPd, and the higher ratio LPd/FQRSd in right than in left precordial leads. The arrhythmia susceptibility did not seem to influence the presence of or properties of LP in the ARVD group. Patients with multiple QRS morphologies during ventricular tachycardia (VT) had, compared with patients with only one type of VT, longer LPd (108.3 +/- 46.4 ms vs. 64.2 +/- 31.7 ms, P less than 0.02) and lower RMS40 voltage (9.4 +/- 9.9 microV vs. 25.4 +/- 21.6 microV, P less than 0.05). The relative heart volume was positively correlated with delayed activity, but an enlarged heart was not a pre-requisite for the presence of LP. The method thus identifies changes which are specific to ARVD. The findings indicate that certain electrical or morphological conditions are required for the occurrence of arrhythmias.

Entities:  

Mesh:

Year:  1988        PMID: 3383870     DOI: 10.1093/oxfordjournals.eurheartj.a062501

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

Review 1.  Localization of cardiac arrhythmias: conventional noninvasive methods.

Authors:  S Yuan; P Blomström; S Pehrson; S B Olsson
Journal:  Int J Card Imaging       Date:  1991

Review 2.  [Arrhythmogenic right ventricular cardiomyopathy. Etiology, diagnosis and therapy].

Authors:  T Wichter; M Borggrefe; G Breithardt
Journal:  Med Klin (Munich)       Date:  1998-04-15

3.  Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Ganesh S Kamath; Wojciech Zareba; Jessica Delaney; Jayanthi N Koneru; William McKenna; Kathleen Gear; Slava Polonsky; Duane Sherrill; David Bluemke; Frank Marcus; Jonathan S Steinberg
Journal:  Heart Rhythm       Date:  2010-10-08       Impact factor: 6.343

4.  Correlation between the parameters of signal-averaged ECG and two-dimensional echocardiography in patients with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Yongwhi Park; Yongkeun Cho; Dong-Yeub Lee; Gui-Lyen Jang; Hyunsang Lee; Dong Heon Yang; Hun-Sik Park; Shung-Chull Chae; Jae-Eun Jun; Wee-Hyun Park
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

Review 5.  Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Pietro Turrini; Domenico Corrado; Cristina Basso; Andrea Nava; Gaetano Thiene
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

Review 6.  Utility of SAECG in arrhythmogenic right ventricle dysplasia.

Authors:  Khurram Nasir; Julie Rutberg; Harikrishna Tandri; Ronald Berger; Gordon Tomaselli; Hugh Calkins
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.